桥接(联网)
背景(考古学)
系统药理学
计算机科学
药物开发
系统生物学
机制(生物学)
管理科学
计算生物学
概念框架
重新使用
药理学
开发(拓扑)
数据科学
临床药理学
模块化设计
生物
风险分析(工程)
数据集成
口译(哲学)
组分(热力学)
过程管理
探索性分析
临床实习
模拟生物系统
生物信息学
作者
Weirong Wang,Alexander Jan Kulesza,Steve Chang,Yougan Cheng,Jingqi Q.X. Gong,Abhishek Gulati,Emma K. Hansson,Alexander Kulesza,Federico Reali,Conner Sandefur,Brian James Schmidt,Fulya Akpinar Singh,Monica E. Susilo,Susana Zaph,Blerta Shtylla
摘要
Quantitative systems pharmacology (QSP) integrates mechanistic representations of biology with quantitative pharmacology to support decision‑making across the drug development continuum. Over the past two decades, QSP has evolved from an exploratory research activity into an established component of model‑informed drug development (MIDD), particularly in settings where system‑level interactions complicate the interpretation of exposure-response relationships or where direct clinical data are limited. This review outlines the historical development and conceptual foundations of QSP and summarizes representative clinical applications spanning early, mid, and late development. Examples highlight how QSP is used to support mechanism-based dose and regimen selection, optimization of combination strategies, biomarker‑informed patient stratification, and lifecycle management decisions. We also discuss considerations for rigor, credibility, and trustworthiness in alignment with the ICH M15 framework, emphasizing clearly defined questions of interest, context of use, and proportional, decision-driven evaluation of assumptions and uncertainty. Finally, we consider emerging challenges and opportunities for QSP adoption, including reuse of platform models, integration of multi-omics data, and selective incorporation of AI-enabled methods within mechanistically interpretable frameworks.
科研通智能强力驱动
Strongly Powered by AbleSci AI